Abstract
Purpose
The purpose of this study was to investigate the characteristics and the outcomes of primary colorectal lymphomas using a population-based registry.
Methods
All cases of colorectal lymphoma diagnosed between 1980 and 2007 were identified using a provincial cancer registry. Patients meeting Dawson’s criteria and having a negative bone marrow biopsy were included.
Results
One hundred ten cases of colorectal lymphoma were identified, 43 met the inclusion criteria. The majority of patients was male (86%), and the median age at diagnosis was 62 (range 26–82) years. Tumors were mostly located in the cecum (51.1%) and rectum (20.9%). The 5-year overall survival rate calculated by the Kaplan–Meier method was 57%. Age under 60 was associated with a better median survival time (265 vs 54 months; p < 0.0001). The surgical treatment was associated with a better overall survival compared to medical treatment alone (110 vs 56 months; p = 0.083). Tumors located in the rectum were associated with a decreased overall survival (41 months vs 110 months; p = 0.065).
Conclusions
Primary colorectal lymphoma is a rare disease. The age at diagnosis is an important predictor of outcome. Surgical resection may be associated with improved survival. Rectal lymphoma appears to be associated with a worse outcome and may warrant more aggressive therapy.
Similar content being viewed by others
References
Glass AG, Karnell LH, Menck HR. The national cancer data base report on non-Hodgkin's lymphoma. Cancer. 1997; 80:2311–20.
Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972; 29:252–60.
Kashimura A, Murakami T. Malignant lymphoma of large intestine—15-year experience and review of literature. Gastroenterol Jpn. 1976;11:141–7.
Henry CA, Berry RE. Primary lymphoma of the large intestine. Am Surg. 1988; 54:262–6.
Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961; 49:80–9
Dionigi G, Annoni M, Rovera F, Boni L, Villa F, Castano P, et al. Primary colorectal lymphomas: Review of the literature. Surg Oncol. 2007; 16 Suppl 1:S169-71.
Jones JL, Loftus EV Jr. Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment? Inflamm Bowel Dis. 2007;13:1299–307
Yoon SO, Suh C, Lee DH, Chi HS, Park CJ, Jang SS Distribution of lymphoid neoplasm in the republic of Korea: analysis of 5318 cases according to the World Health Organization classification Am J Hematol. 2010; 85:760–4
Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: The microscope as a tool for disease discovery. Blood. 2008;112:4384–99.
Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas (author's transl). Strahlentherapie. 1977; 153:218–21.
Wong MT, Eu KW. Primary colorectal lymphomas. Colorectal Dis. 2006; 8:586–91.
Musallam KM, Hatoum HA, Barada K, Taher AT, Salem ME, Malek EM, et al. (2010) Primary colorectal lymphoma. Med Oncol 27(2):249–54
Aviles A, Neri N, Huerta-Guzman J. Large bowel lymphoma: An analysis of prognostic factors and therapy in 53 patients. J Surg Oncol. 2002; 80:111–5.
Zighelboim J, Larson MV. Primary colonic lymphoma. clinical presentation, histopathologic features, and outcome with combination chemotherapy. J Clin Gastroenterol. 1994; 18:291–7.
Doolabh N, Anthony T, Simmang C, Bieligk S, Lee E, Huber P, et al. Primary colonic lymphoma. J Surg Oncol. 2000; 74:257–62.
Lenzen R, Borchard F, Lubke H, Strohmeyer G. Colitis ulcerosa complicated by malignant lymphoma: Case report and analysis of published works. Gut. 1995; 36:306–10.
Bargen JA (1928) Chronic ulcerative colitis associated with malignant disease. Arch Surg 17: 561–76
Robert ME, Kuo FC, Longtine JA, Sklar JL, Schrock T, Weidner N. Diffuse colonic mantle cell lymphoma in a patient with presumed ulcerative colitis: Detection of a precursor monoclonal lymphoid population using polymerase chain reaction and immunohistochemistry. Am J Surg Pathol. 1996; 20:1024–31.
Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, et al. The epidemiology of inflammatory bowel disease in canada: A population-based study. Am J Gastroenterol. 2006; 101:1559–68.
Parente F, Rizzardini G, Cernuschi M, Antinori S, Fasan M, Bianchi Porro G. Non-Hodgkin's lymphoma and AIDS: Frequency of gastrointestinal involvement in a large italian series. Scand J Gastroenterol. 1993; 28:315–8.
Cai S, Cannizzo F,Jr, Bullard Dunn KM, Gibbs JF, Czuczman M, Rajput A. The role of surgical intervention in non-Hodgkin's lymphoma of the colon and rectum. Am J Surg. 2007; 193:409–12
Fan CW, Changchien CR, Wang JY, Chen JS, Hsu KC, Tang R, et al. Primary colorectal lymphoma. Dis Colon Rectum. 2000; 43:1277–82.
Gonzalez QH, Heslin MJ, Davila-Cervantes A, Alvarez-Tostado J, de los Monteros AE, Shore G, et al. Primary colonic lymphoma. Am Surg. 2008; 74:214–6.
Wang MH, Wong JM, Lien HC, Lin CW, Wang CY. Colonoscopic manifestations of primary colorectal lymphoma. Endoscopy. 2001; 33:605–9.
Myung SJ, Joo KR, Yang SK, Jung HY, Chang HS, Lee HJ, et al. Clinicopathologic features of ileocolonic malignant lymphoma: Analysis according to colonoscopic classification. Gastrointest Endosc. 2003; 57:343–7.
Devine RM, Beart RW,Jr, Wolff BG. Malignant lymphoma of the rectum. Dis Colon Rectum. 1986; 29:821–4.
Perry PM, Cross RM, Morson BC. Primary malignant lymphoma of the rectum (22 cases). Proc R Soc Med. 1972; 65:72.
Balfe P, O'Brian S, Daly P, Reynolds JV. Management of gastric lymphoma. Surgeon. 2008; 6:262–5.
Law MM, Williams SB, Wong JH. Role of surgery in the management of primary lymphoma of the gastrointestinal tract. J Surg Oncol. 1996; 61:199–204.
Zinzani PL, Magagnoli M, Pagliani G, Bendandi M, Gherlinzoni F, Merla E, et al. Primary intestinal lymphoma: Clinical and therapeutic features of 32 patients. Haematologica. 1997; 82:305–8.
Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera international trial (MInT) group. Lancet Oncol. 2006; 7:379–91.
Disclaimers/Conflicts
No conflicts of interest exist.
Grant Support
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Poster Presentation
This study was included as a poster presentation during the ASCRS Annual Meeting on May 15–19, 2010 at Minneapolis, MN, USA.
Rights and permissions
About this article
Cite this article
Drolet, S., Maclean, A.R., Stewart, D.A. et al. Primary Colorectal Lymphoma—Clinical Outcomes in a Population-Based Series. J Gastrointest Surg 15, 1851–1857 (2011). https://doi.org/10.1007/s11605-011-1572-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-011-1572-0